• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠μ-阿片受体的C末端剪接变体在吗啡诱导的内化和受体再敏化方面存在差异。

C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization.

作者信息

Koch T, Schulz S, Pfeiffer M, Klutzny M, Schröder H, Kahl E, Höllt V

机构信息

Department of Pharmacology and Toxicology, Otto-von-Guericke University, 39120 Magdeburg, Germany.

出版信息

J Biol Chem. 2001 Aug 17;276(33):31408-14. doi: 10.1074/jbc.M100305200. Epub 2001 May 18.

DOI:10.1074/jbc.M100305200
PMID:11359768
Abstract

The main analgesic effects of the opioid alkaloid morphine are mediated by the mu-opioid receptor. In contrast to endogenous opioid peptides, morphine activates the mu-opioid receptor without causing its rapid endocytosis. Recently, three novel C-terminal splice variants (MOR1C, MOR1D, and MOR1E) of the mouse mu-opioid receptor (MOR1) have been identified. In the present study, we show that these receptors differ substantially in their agonist-selective membrane trafficking. MOR1 and MOR1C stably expressed in human embryonic kidney 293 cells exhibited phosphorylation, internalization, and down-regulation in the presence of the opioid peptide [d-Ala(2),Me-Phe(4),Gly(5)-ol]enkephalin (DAMGO) but not in response to morphine. In contrast, MOR1D and MOR1E exhibited robust phosphorylation, internalization, and down-regulation in response to both DAMGO and morphine. DAMGO elicited a similar desensitization (during an 8-h exposure) and resensitization (during a 50-min drug-free interval) of all four mu-receptor splice variants. After morphine treatment, however, MOR1 and MOR1C showed a faster desensitization and no resensitization as compared with MOR1D and MOR1E. These results strongly reinforce the hypothesis that receptor phosphorylation and internalization are required for opioid receptor reactivation thus counteracting agonist-induced desensitization. Our findings also suggest a mechanism by which cell- and tissue-specific C-terminal splicing of the mu-opioid receptor may significantly modulate the development of tolerance to the various effects of morphine.

摘要

阿片类生物碱吗啡的主要镇痛作用是由μ-阿片受体介导的。与内源性阿片肽不同,吗啡激活μ-阿片受体而不会导致其快速内吞。最近,已鉴定出小鼠μ-阿片受体(MOR1)的三种新型C末端剪接变体(MOR1C、MOR1D和MOR1E)。在本研究中,我们表明这些受体在激动剂选择性膜转运方面存在显著差异。在人胚肾293细胞中稳定表达的MOR1和MOR1C在阿片肽[d-Ala(2),Me-Phe(4),Gly(5)-ol]脑啡肽(DAMGO)存在下表现出磷酸化、内化和下调,但对吗啡无反应。相比之下,MOR1D和MOR1E对DAMGO和吗啡均表现出强烈的磷酸化、内化和下调。DAMGO在8小时暴露期间对所有四种μ-受体剪接变体引发了类似的脱敏作用(在50分钟无药间隔期间)和再敏化作用。然而,与MOR1D和MOR1E相比,吗啡处理后,MOR1和MOR1C表现出更快的脱敏作用且无再敏化作用。这些结果有力地支持了以下假设:受体磷酸化和内化是阿片受体重新激活所必需的,从而抵消激动剂诱导的脱敏作用。我们的研究结果还提出了一种机制,通过该机制μ-阿片受体的细胞和组织特异性C末端剪接可能会显著调节对吗啡各种作用的耐受性发展。

相似文献

1
C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization.小鼠μ-阿片受体的C末端剪接变体在吗啡诱导的内化和受体再敏化方面存在差异。
J Biol Chem. 2001 Aug 17;276(33):31408-14. doi: 10.1074/jbc.M100305200. Epub 2001 May 18.
2
Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.人胚肾293细胞中μ-阿片受体脱敏的激动剂选择性机制
Mol Pharmacol. 2006 Aug;70(2):676-85. doi: 10.1124/mol.106.022376. Epub 2006 May 8.
3
Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization.大鼠μ阿片受体的羧基末端剪接调节激动剂介导的内化和受体再敏化。
J Biol Chem. 1998 May 29;273(22):13652-7. doi: 10.1074/jbc.273.22.13652.
4
Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor.A118G多态性对人μ-阿片受体的结合亲和力、效力以及激动剂介导的内吞作用、脱敏和再敏化的影响。
J Neurochem. 2004 May;89(3):553-60. doi: 10.1111/j.1471-4159.2004.02340.x.
5
Role of phospholipase D2 in the agonist-induced and constitutive endocytosis of G-protein coupled receptors.磷脂酶D2在激动剂诱导的和组成型的G蛋白偶联受体内吞作用中的作用。
J Neurochem. 2006 Apr;97(2):365-72. doi: 10.1111/j.1471-4159.2006.03736.x. Epub 2006 Mar 15.
6
C-terminal splice variants of the mu-opioid receptor: existence, distribution and functional characteristics.μ-阿片受体的C末端剪接变体:存在、分布及功能特性
J Neurochem. 2008 Feb;104(4):937-45. doi: 10.1111/j.1471-4159.2007.05057.x. Epub 2007 Nov 14.
7
Replacement of threonine 394 by alanine facilitates internalization and resensitization of the rat mu opioid receptor.将苏氨酸394替换为丙氨酸可促进大鼠μ阿片受体的内化和再敏化。
Mol Pharmacol. 1999 Feb;55(2):263-8. doi: 10.1124/mol.55.2.263.
8
Mu-opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine.成熟大鼠神经元中的μ-阿片受体脱敏:DAMGO与吗啡之间缺乏相互作用。
J Neurosci. 2003 Nov 19;23(33):10515-20. doi: 10.1523/JNEUROSCI.23-33-10515.2003.
9
RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.RGS14可阻止吗啡使中脑导水管周围灰质神经元中的μ-阿片受体内化。
Cell Signal. 2007 Dec;19(12):2558-71. doi: 10.1016/j.cellsig.2007.08.003. Epub 2007 Aug 15.
10
Mu opioid receptor-effector coupling and trafficking in dorsal root ganglia neurons.背根神经节神经元中μ阿片受体-效应器偶联及转运
Neuroscience. 2006 Oct 13;142(2):493-503. doi: 10.1016/j.neuroscience.2006.06.021. Epub 2006 Aug 1.

引用本文的文献

1
A Balancing Act: Learning from the Past to Build a Future-Focused Opioid Strategy.平衡之道:从过去中汲取经验,构建以未来为导向的阿片类药物策略。
Annu Rev Physiol. 2024 Feb 12;86:1-25. doi: 10.1146/annurev-physiol-042022-015914. Epub 2023 Nov 29.
2
Design and development of novel, short, stable dynorphin-based opioid agonists for safer analgesic therapy.设计和开发新型、短效、稳定的基于强啡肽的阿片类激动剂用于更安全的镇痛治疗。
Front Pharmacol. 2023 Mar 3;14:1150313. doi: 10.3389/fphar.2023.1150313. eCollection 2023.
3
Cellular Tolerance Induced by Chronic Opioids in the Central Nervous System.
慢性阿片类药物在中枢神经系统中诱导的细胞耐受性。
Front Syst Neurosci. 2022 Jun 28;16:937126. doi: 10.3389/fnsys.2022.937126. eCollection 2022.
4
Attenuated G protein signaling and minimal receptor phosphorylation as a biochemical signature of low side-effect opioid analgesics.作为低副作用阿片类镇痛药的生化特征,减弱的 G 蛋白信号和最小的受体磷酸化。
Sci Rep. 2022 May 3;12(1):7154. doi: 10.1038/s41598-022-11189-6.
5
Exploring Pharmacological Functions of Alternatively Spliced Variants of the Mu Opioid Receptor Gene, , via Gene-Targeted Animal Models.通过基因靶向动物模型探索 μ 阿片受体基因 ,剪接变体的药理学功能。
Int J Mol Sci. 2022 Mar 10;23(6):3010. doi: 10.3390/ijms23063010.
6
Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene, : Insight into Complex Mu Opioid Actions.μ 阿片受体基因的可变前体 mRNA 剪接:深入了解复杂的 μ 阿片类药物作用。
Biomolecules. 2021 Oct 15;11(10):1525. doi: 10.3390/biom11101525.
7
HA-MOP knockin mice express the canonical µ-opioid receptor but lack detectable splice variants.HA-MOP 敲入小鼠表达经典的 μ 阿片受体,但缺乏可检测的剪接变体。
Commun Biol. 2021 Sep 14;4(1):1070. doi: 10.1038/s42003-021-02580-6.
8
Modulation of OPRM1 Alternative Splicing by Morphine and HIV-1 Nef.吗啡和 HIV-1 Nef 对 OPRM1 可变剪接的调节。
J Neuroimmune Pharmacol. 2022 Jun;17(1-2):277-288. doi: 10.1007/s11481-021-10009-4. Epub 2021 Aug 21.
9
Mu Opioids Induce Biased Signaling at the Full-Length Seven Transmembrane C-Terminal Splice Variants of the mu Opioid Receptor Gene, Oprm1.μ 阿片类物质在全长七跨膜 C 端剪接变异体 μ 阿片受体基因 Oprm1 上诱导偏向信号传导。
Cell Mol Neurobiol. 2021 Jul;41(5):1059-1074. doi: 10.1007/s10571-020-00973-5. Epub 2020 Oct 8.
10
Relevance of Mu-Opioid Receptor Splice Variants and Plasticity of Their Signaling Sequelae to Opioid Analgesic Tolerance.μ-阿片受体剪接变体及其信号后遗症的可塑性与阿片类镇痛耐受性的相关性
Cell Mol Neurobiol. 2021 Jul;41(5):855-862. doi: 10.1007/s10571-020-00934-y. Epub 2020 Aug 17.